![](/fileadmin/_processed_/csm_Amphistar_c6faa8b918.jpg)
AmphiStar BV secures €6m to expand production
The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart commercial biosurfactant production in...
![](/fileadmin/_processed_/csm_anacura_griet_ohmxbio_104d007f0f.jpg)
Anacura aquires Ohmx.bio
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a also...
![](/fileadmin/Content/NewsAndStories/2024/Rentschler_Biopharma_new_line_PR_SM.png)
Rentschler doubles cGMP capacity
According to a company spokesperson, the expansion in the main market for biopharmaceuticals doubles Rentschler's cGMP-compliant production capacity...
![](/fileadmin/_processed_/csm_SFactory01_Launch_044ec847f4.png)
Solar Foods starts Factory01
Following market authorisation in Singapore two years ago, the Finnish company Solar Foods Oy and the Japanese food giant Ajinomoto Group want to...
![](/fileadmin/_processed_/csm_quantro_747ee92cb9.png)
Quantro Therapeutics cashes in milestone payment from Boehringer Ingelheim
Austrian QUANTRO Therapeutics GmbH has reached a key milestone in its three year R&D and licence option collaboration with Boehringer...
![](/fileadmin/_processed_/csm_Elsie_e778d3c6d7.png)
GSK closes US$50m acquisition with Elsie Biotechnologies Inc
GlaxoSmithKline (GSK) plc has acquired Elsie Biotechnologies Inc, a San Diego-based biotechcompany dedicated to unlocking the potential of...
![](/fileadmin/_processed_/csm_CordenPharma-Peptide-Expansion-Press-Release-16-July-2024-for-Web-1-1024x614_520d0c7270.jpg)
CordenPharma invests €900m in peptide patform expansion
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its peptide...